secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2023-10-04T23:59:59+00:00
Accession:  0001193125-23-250405
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex raises ~$8.7M in public offering of common stock and warrants
----------------------------------------------------------------------

- Sold 9.6M share equivalents (7.6M shares + 2M pre-funded warrants) at $1.00 per unit, raising ~$8.7M net.
- Related parties (Chairman Friedberg and CEO Zauderer) purchased $3.5M of shares and warrants in the offering.
- Common warrants have $1.00 exercise price, 5-year term; pre-funded warrants have $0.0001 exercise price.
- Net proceeds to fund pepinemab development for Alzheimer's disease and cancer, plus working capital.
- Insiders entered lock-up agreements through December 2, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523250405/0001193125-23-250405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523250405/d539255d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-250405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer